Welcome!
You have no items in your shopping cart.
Phase 0 Biomarker Trials: A New Paradigm for Oncology Drug Development?
A New Paradigm for Understanding Excess Cancer Risk in Underserved and Minority Populations: The Centers for Population Health and Health Disparities Experience
Prostate Cancer: Latent versus Clinically Significant Disease: Does Every Cancer Need Intervention?
NATHAN A. BERGER; Poly(ADP-ribose), Polymerase Function and Activities
From Molecular Tumor Markers to Health Behaviors: Promises and Challenges of Cancer Survivorship